June 19, the National Health Insurance Bureau on the new coronavirus test to do a good job in the network procurement, price management and health insurance payment work issued a notice, notice is as follows:
A smooth reagent purchasing channels
(a) generally carry out open network procurement. Local medicine centralized purchasing agencies should do a good job of the new coronavirus testing reagents listed on the network, improve the provincial centralized purchasing platform between the information **** enjoy, price linkage mechanism. Public medical institutions should purchase new coronavirus test reagents from the provincial centralized purchasing platform of pharmaceutical consumables in their provinces.
(ii) Encourage centralized procurement. Provincial and regional health insurance departments are encouraged to actively explore centralized procurement of new coronavirus testing reagents, selecting enterprises with higher product quality, stronger production capacity, stable supply and better integrity, and promoting the return of prices to reasonable levels through competition.
Second, improve the testing program price policy
(a) testing program is not "according to the disease". In principle, do not distinguish between pathogens or operational steps to set up a new nucleic acid, antibody test price items; Class A infectious diseases or according to the law of Class A management of infectious diseases related to the examination, such as the risk of difficulty, high protection requirements, can be based on the prevailing price of the project to develop a unified policy of charging more. Public medical institutions for the new coronavirus nucleic acid, antibody testing, can directly implement the existing fee policy, without the need to apply for new price items.
(ii) a single temporary project to reflect the "separation of technology and consumption". Indeed need to set up a single temporary project to meet the public medical institutions new coronavirus testing fees demand, to encourage localities according to the "technology and consumption of separation" way to set up the project. Nucleic acid, antibody test sample collection, processing, labeling, recycling, diagnostic results, as well as nasopharyngeal swabs and other consumables should be combined as a medical service price item pricing; in vitro diagnostic kits in the price of medical services outside of the project, in accordance with the "zero-differential rate" charges.
Three, do a good job of medical insurance payment
We must take into account the new coronavirus pneumonia prevention and control needs, the region's ability to pay the medical insurance fund and other factors on the basis of the procedure for the new coronavirus nucleic acid, antibody testing projects and related supplies into the provincial medical insurance diagnostic and treatment program directory, and synchronize the determination of payment conditions. The medical insurance departments of all regions should attach great importance to this issue. Local health insurance departments should attach great importance to this work, and please report to the National Health Security Bureau in a timely manner when encountering major problems and situations in the course of work.
Expanded information:
The Daily Economic News reporter noted that there are already provinces actively exploring. Recently, the Heilongjiang Provincial Medical Protection Bureau to explore the new crown virus detection reagents online centralized procurement work. Under the premise of guaranteeing the supply of play "group purchase" advantage, the centralized procurement reagents lowest winning price of 16.78 yuan, the average winning price of 20.89 yuan, price reduction of about 70%.
After the test reagent price reduction, the Heilongjiang Provincial Bureau of Medical Protection and the new coronavirus nucleic acid test price of scientific and reasonable pricing, clear the province's public medical institutions at all levels of nucleic acid test charges up to a maximum of 135 yuan, so as to reduce the burden on the people.
Recently, the Anhui Provincial Bureau of Medical Protection has also been actively carrying out provincial centralized purchasing of new coronary virus-related testing reagents. Through the centralized procurement of nucleic acid testing reagents, antibody testing reagents products listed limit price compared with the original actual purchase price of medical institutions in Anhui Province, the average price reduction of 83% and 67%.
People's Daily Online - National Health Insurance Bureau: localities should follow the procedures to include nucleic acid testing and other items into the health insurance